Explore our newest method development application focusing on the determination of residual solvents and terpenes in cannabis by GC-FID. Below is a snippet from our recently published technical note by Continue Reading
The United States Pharmacopeia (USP) has defined the limits of “allowable adjustments” in USP General Chapter <621>, where revalidation is required if adjustment limits are exceeded. Even though this chapter Continue Reading
Last month, Phenomenex hosted the SoCal Dietary Supplements Chromatography Forum—an all-day assembly co-sponsored by Alkemist Laboratories and US Pharmacopeia (USP) to discuss “the need and approach to modernizing USP dietary supplement monographs,” particularly those based upon chromatography.
Effective August 2014, the United States Pharmacopoeia and the National Formulary published the latest revision to General Chapter on Chromatography that further clarifies what “allowable adjustments” can be made to USP methods without having to revalidate these methods.